1-3 of 3
Patti Thiemann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Bruton's Tyrosine Kinase (BTK) Inhibitor PCI-32765 Inhibits Growth of ABC DLBCL Tumors In Vivo and in Vitro by Preventing Activation of Pro-Survival NF-κB pathways

Free
Sriram Balasubramanian, PhD, Richard Crowley, MS, Mint Sirisawad, MS, Patti Thiemann, MS, Jun Chen, PhD, Joseph J. Buggy, PhD
Journal: Blood
Blood (2011) 118 (21): 4969.
https://doi.org/10.1182/blood.V118.21.4969.4969
Published: 2011
Journal Articles

Targeting Btk in Lymphoma: PCI-32765 Inhibits Tumor Growth in Mouse Lymphoma Models and a Fluorescent Analog of PCI-32765 Is an Active-Site Probe That Enables Assessment of Btk Inhibition In Vivo .

Free
Lee A. Honigberg, PhD, Ashley M. Smith, B.S., Jun Chen, Ph.D., Patti Thiemann, B.S., Erik Verner, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1592.
https://doi.org/10.1182/blood.V110.11.1592.1592
Published: 2007
Journal Articles

Sapphyrins Exhibit Tumor Selectivity and Efficacy in Animal Models of Hematologic Malignancies.

Free
Louie Naumovski, MD-PhD, Mint Sirisawad, BA, Philip Lecane, PhD, Jason Ramos, PhD, Darren Magda, PhD, Zhong Wang, PhD, Patti Thiemann, BS, Garry Boswell, PharmD, Dong-Gyu Cho, BS, Jonathan Sessler, PhD, Richard A. Miller, MD
Journal: Blood
Blood (2004) 104 (11): 2501.
https://doi.org/10.1182/blood.V104.11.2501.2501
Published: 2004